List of insiders holdings for Foghorn Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
2024-05-24 17:00:59 | 16,303,949 0 |
16,303,949 | Form 13D |
| 2 | KADOCH CIGALL Director |
2022-09-02 08:07:29 | 323,530 3,329,379 |
3,652,909 | Form 4 |
| 3 | Flagship Pioneering Inc. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Special Opportunities Fund II L.P. AFEYAN NOUBAR 10% Owner |
2024-05-24 17:05:08 | 0 3,629,829 |
3,629,829 | Form 4 |
| 4 | Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. 10% Owner |
2024-05-24 17:00:10 | 0 1,814,915 |
1,814,915 | Form 3 |
| 5 | Abu Dhabi Investment Authority Platinum International Investment Holding RSC Ltd Platinum Falcon B 2018 RSC Ltd Former 10% Owner |
2020-10-28 06:02:15 | 1,231,081 0 |
1,231,081 | Form 4 |
| 6 | Reine Allan Chief Financial Officer |
2024-01-17 16:01:54 | 748,188 0 |
748,188 | Form 4 |
| 7 | DECICCO CARL Chief Scientific Officer |
2021-12-13 20:37:39 | 583,551 0 |
583,551 | Form 4 |
| 8 | GOTTSCHALK ADRIAN Chief Executive Officer |
2025-04-10 16:01:26 | 0 511,704 |
511,704 | Form 4 |
| 9 | Cavalie Fanny Chief Strategy/Bus Ops Officer |
2024-06-24 16:01:17 | 482,161 0 |
482,161 | Form 4 |
| 10 | Agresta Samuel Chief Medical Officer |
2023-09-13 16:02:28 | 376,891 0 |
376,891 | Form 4 |
| 11 | Bellon Steven F. Chief Scientific Officer |
2025-01-24 16:09:02 | 140,000 0 |
140,000 | Form 4 |
| 12 | LaCascia Michael Chief Legal Officer |
2025-01-24 16:06:45 | 126,000 0 |
126,000 | Form 4 |
| 13 | Cardama Alfonso Quintas Chief Medical Officer |
2025-01-24 16:16:18 | 125,000 0 |
125,000 | Form 4 |
| 14 | Humer Kristian Chief Financial Officer |
2025-01-24 16:15:38 | 120,000 0 |
120,000 | Form 4 |
| 15 | Costa Carlos Chief People Officer |
2025-01-24 16:13:52 | 115,000 0 |
115,000 | Form 4 |
| 16 | Baselga Jose Director |
2020-10-22 20:56:11 | 94,594 0 |
94,594 | Form 3 |
| 17 | Rivkin Anna Chief Business Officer |
2025-01-24 16:11:43 | 50,000 0 |
50,000 | Form 4 |
| 18 | Biller Scott Director |
2024-06-28 16:08:04 | 16,000 0 |
16,000 | Form 4 |
| 19 | Mendelsohn Michael Director |
2024-06-28 16:07:38 | 16,000 0 |
16,000 | Form 4 |
| 20 | SMITH IAN F Director |
2024-06-28 16:06:35 | 16,000 0 |
16,000 | Form 4 |
| 21 | Lynch Thomas J. Jr. Director |
2024-06-28 16:06:10 | 16,000 0 |
16,000 | Form 4 |
| 22 | GILL SIMBA Director |
2024-06-28 16:04:41 | 16,000 0 |
16,000 | Form 4 |
| 23 | Cole Douglas G. Director |
2024-06-28 16:03:47 | 16,000 0 |
16,000 | Form 4 |
| 24 | PARSHALL B LYNNE Director |
2024-06-28 16:02:16 | 16,000 0 |
16,000 | Form 4 |
| 25 | Koppel Adam Director |
2024-12-30 07:54:56 | 0 0 |
0 | Form 4 |